prof. dr. E.G.E. (Elisabeth) de Vries

Professor

No picture available
E-mail:
e.g.e.de.vries umcg.nl

Research

  1. 2020
  2. Molecular Imaging for Immunotherapy

    Elisabeth G. E. Vries, de (Invited speaker)
    21-Jan-2020

    Activity: Talk or presentationProfessional

  3. 2019
  4. Imaging and nuclear medicine

    Elisabeth G. E. Vries, de (Invited speaker)
    12-Dec-2019

    Activity: Talk or presentationProfessional

  5. ESMO Magnitude of Clinical Benefit Scale (MCBS): Present status and online tools

    Elisabeth G. E. Vries, de (Invited speaker)
    22-Nov-2019

    Activity: Talk or presentationProfessional

  6. Imaging of immune checkpoints

    Elisabeth G. E. Vries, de (Invited speaker)
    27-Oct-2019

    Activity: Talk or presentationProfessional

  7. ESMO Magnitude of Clinical Benefit Scale

    Elisabeth G. E. Vries, de (Invited speaker)
    13-Oct-2019

    Activity: Talk or presentationProfessional

  8. Global Access to Good Quality Medicines

    Elisabeth G. E. Vries, de (Invited speaker)
    12-Oct-2019

    Activity: Talk or presentationProfessional

  9. Immunotherapy and therapy prediction / PET imaging, PD-L1

    Elisabeth G. E. Vries, de (Invited speaker)
    3-Oct-2019

    Activity: Talk or presentationAcademic

  10. ESMO’s emerging perspective, access to cancer medicines

    Elisabeth G. E. Vries, de (Invited speaker)
    1-Jun-2019

    Activity: Talk or presentationProfessional

  11. Molecular imaging of PD-L1

    Elisabeth G. E. Vries, de (Invited speaker)
    29-Apr-2019

    Activity: Talk or presentationProfessional

  12. PD-L1 imaging in melanoma and other tumors

    Elisabeth G. E. Vries, de (Invited speaker)
    26-Apr-201928-Apr-2019

    Activity: Talk or presentationProfessional

  13. ESMO-MCBS and lessons to be learned for leadership

    Elisabeth G. E. Vries, de (Invited speaker)
    7-Apr-2019

    Activity: Talk or presentationProfessional

  14. Imaging biomarkers

    Elisabeth G. E. Vries, de (Invited speaker)
    26-Feb-2019

    Activity: Talk or presentationProfessional

  15. 2018
  16. Imgaing of checkpoint inhibition

    E. G. E. de Vries (Invited speaker)
    14-Dec-2018

    Activity: Talk or presentationProfessional

  17. The BIG picture: Molecular imaging and breast cancer

    E. G. E. de Vries (Invited speaker)
    22-Nov-2018

    Activity: Talk or presentationProfessional

  18. Use of frameworks to judge cancer drugs and implementation of the ESMO-MCBS

    E. G. E. de Vries (Invited speaker)
    18-Nov-2018

    Activity: Talk or presentationProfessional

  19. Availability of medicines: impact on public health

    E. G. E. de Vries (Invited speaker)
    9-Nov-2018

    Activity: Talk or presentationProfessional

  20. The use of difference frameworks in oncology to grade drugs

    E. G. E. de Vries (Invited speaker)
    22-Oct-2018

    Activity: Talk or presentationProfessional

  21. Quantifying tumour response: Clinical perspective

    E. G. E. de Vries (Invited speaker)
    10-Oct-2018

    Activity: Talk or presentationProfessional

  22. ESMO Magnitude of Clinical Benefit Scale: a tool for a more adequate value-base reimbursement

    E. G. E. de Vries (Invited speaker)
    20-Jul-2018

    Activity: Talk or presentationProfessional

  23. TED talk "Road to Success"

    E. G. E. de Vries (Invited speaker)
    29-Jun-2018

    Activity: Talk or presentationProfessional

  24. Imaging with Checkpoint Inhibitors

    E. G. E. de Vries (Invited speaker)
    25-Jun-2018

    Activity: Talk or presentationProfessional

  25. ESMO-MCBS

    E. G. E. de Vries (Invited speaker)
    29-Mar-2018

    Activity: Talk or presentationProfessional

  26. Current and future role of molecular imaging in oncology

    E. G. E. de Vries (Invited speaker)
    21-Mar-2018

    Activity: Talk or presentationProfessional

  27. Interpreting the ESMO-MCBS

    E. G. E. de Vries (Invited speaker)
    17-Mar-2018

    Activity: Talk or presentationProfessional

ID: 162081